Founders Capital Management, LLC Amgen Inc Transaction History

Founders Capital Management, LLC

$571 Million
Q3 2024

A detailed history of Founders Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Founders Capital Management, LLC holds 20,034 shares of AMGN stock, worth $5.28 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

20,034

Previous 20,125 0.45%

Holding current value

$5.28 Million

Previous $6.29 Million 2.66%

% of portfolio

1.13%

Previous 1.14%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $28,153 - $30,701	-91 Reduced 0.45%	20,034 $6.46 Million
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $58,593 - $71,206	-223 Reduced 1.1%	20,125 $6.29 Million
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $1.28 Million - $1.44 Million	5,000 Added 32.58%	20,348 $5.86 Million
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $64,709 - $76,517	-302 Reduced 1.93%	15,348 $3.41 Million
Q4 2021 Jan 27, 2022	BUY	$198.88 - $227.6 $59,465 - $68,052	299 Added 1.95%	15,650 $3.52 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $44,788 - $52,475	211 Added 1.39%	15,351 $3.26 Million
Q2 2021 Jul 15, 2021	SELL	$233.58 - $259.14 $460,619 - $511,024	-1,972 Reduced 11.52%	15,140 $3.69 Million
Q1 2021 Apr 12, 2021	BUY	$221.91 - $258.6 $437,606 - $509,959	1,972 Added 13.03%	17,112 $4.26 Million
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $234 - $260	-1 Reduced 0.01%	15,140 $3.85 Million
Q1 2020 Apr 20, 2020	BUY	$182.24 - $241.7 $16,401 - $21,753	90 Added 0.6%	15,141 $3.07 Million
Q3 2019 Oct 09, 2019	SELL	$174.11 - $208.62 $13,058 - $15,646	-75 Reduced 0.5%	15,051 $2.94 Million
Q2 2019 Jul 11, 2019	BUY	$166.7 - $195.41 $24,504 - $28,725	147 Added 0.98%	15,126 $2.79 Million
Q1 2019 Apr 16, 2019	BUY	$180.87 - $203.88 $1.01 Million - $1.14 Million	5,580 Added 59.37%	14,979 $2.85 Million
Q4 2018 Jan 15, 2019	SELL	$178.4 - $208.25 $95,622 - $111,622	-536 Reduced 5.4%	9,399 $1.83 Million
Q3 2017 Oct 24, 2017	SELL	$167.29 - $191.0 $107,902 - $123,195	-645 Reduced 6.1%	9,935 $1.85 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $1.77 Million - $2.02 Million	10,580	10,580 $1.85 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management, LLC with notifications on news.

Account

Founders Capital Management, LLC Amgen Inc Transaction History